Histidine

SCHEMBL7758642

CC(C)C[C@H](N)C(=O)O.CC[C@H](C)[C@H](N)C(=O)O.CSCC[C@H](N)C(=O)O.C[C@@H](O)[C@H](N)C(=O)O.NC(=O)C[C@H](N)C(=O)O.NCC(=O)O.NCC(=O)O.NCC(=O)O.NCCCC[C@H](N)C(=O)O.N[C@@H](CS)C(=O)O.N[C@@H](CS)C(=O)O.N[C@@H](Cc1c[nH]cn1)C(=O)O.O=C(O)[C@@H]1CCCN1.O=C(O)[C@@H]1CCCN1.O=C(O)[C@@H]1CCCN1

nearest known ligand 0.34

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

PPARD PTGS1 PTGS2 dacA dacB dacC ftsI mrcA mrcB mrdA

The experimentally established mechanism targets of Histidine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 6)

	gene	UniProt	supporting neighbours	confidence
▸	CALCR	P30988	4/20	0.34

▸	CRHR1	P34998	1/20	0.33

▸	CRHR2	Q13324	1/20	0.33

▸	NPY1R	P25929	1/20	0.30

▸	NPY2R	P49146	1/20	0.30

▸	REN	P00797	1/20	0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compound	similarity	top predicted	shared targets
Histidine SCHEMBL7756453	0.95	CALCR (0.32)	CALCRCRHR1CRHR2
Histidine SCHEMBL7758637	0.94	CALCR (0.32)	CALCRCRHR1CRHR2
Histidine SCHEMBL6556855	0.93	CALCR (0.32)	CALCRCRHR1CRHR2
Histidine SCHEMBL6554544	0.90	MEN1 (0.30)	—
Phenylalanine SCHEMBL28835549	0.90	CALCR (0.40)	CALCRCRHR1CRHR2NPY1RNPY2R
Histidine SCHEMBL7756448	0.88	—	—
Tyrosine SCHEMBL27498286	0.86	CALCR (0.40)	CALCRCRHR1CRHR2
Histidine SCHEMBL29169735	0.86	HCRTR1 (0.30)	—
Tryptophan SCHEMBL28943517	0.85	PTH1R (0.38)	CALCR
Histidine SCHEMBL5578065	0.85	—	—

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

Patent	Title	Assignee	Published	Priority	Filing	Country	Status
EP-1082340-A1	PEPTIDE VACCINE FOR CANINE ALLERGY	IDEXX LABORATORIES, INC. (US)	2001-03-14	—	—	EP	claimed
WO-2000058349-A1	PEPTIDE VACCINE FOR CANINE ALLERGY	IDEXX LABORATORIES, INC. (US)	2000-10-05	—	—	WO	claimed